Hatch Medical has successfully brokered the sale of Novotek Innovation’s novel intellectual property portfolio for endovascular repair of abdominal aortic aneurysms. The undisclosed purchase price consisted of a combined cash and stock payment.
“It has been a pleasure to represent Novotek, a UK-based company, through this transaction. The Novotek platform will help resolve the many critical issues associated with today’s endovascular aneurysm repair technologies,” stated Steve Hvozda, principal at Hatch Medical.
Peter Harris, vascular surgeon and director of Novotek, added, “We are pleased to have had the expertise and assistance of Hatch Medical to successfully negotiate a suitable transaction that recognises the potential value of these innovations.”
